विवरण
A PRISMA-style flowchart shows the study selection process for the review on gut microbiota-targeted therapeutics for metabolic disorders. Databases searched, inclusion and exclusion criteria, and the final number of analyzed studies are documented.
Figure 35
FlowchartSource Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 35: A PRISMA-style flowchart shows the study selection process for the review on gut microbiota-targeted therapeutics for metabolic disorders. Databases searched, inclusion and exclusion criteria, and the final number of analyzed studies are documented.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="A PRISMA-style flowchart shows the study selection process for the review on gut microbiota-targeted therapeutics for metabolic disorders. Databases searched, inclusion and exclusion criteria, and the final number of analyzed studies are documented." /> <figcaption>Figure 35. A PRISMA-style flowchart shows the study selection process for the review on gut microbiota-targeted therapeutics for metabolic disorders. Databases searched, inclusion and exclusion criteria, and the final number of analyzed studies are documented.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>